Calorie Restriction Linked to Sustained Metabolic Adaptation

Share this content:
Calorie Restriction Linked to Sustained Metabolic Adaptation
Calorie Restriction Linked to Sustained Metabolic Adaptation

THURSDAY, March 22, 2018 (HealthDay News) -- Calorie restriction (CR) over two years is associated with considerable weight loss, and with lower than expected energy expenditure (EE) relative to the weight loss, according to a study published online March 22 in Cell Metabolism.

Leanne M. Redman, Ph.D., from the Biochemical Research Center in Baton Rouge, La., and colleagues examined whether EE and its endocrine mediators are reduced with a CR diet over two years in a study involving 34 CR and 10 control non-obese adults.

The researchers found that about 15 percent CR was achieved over two years, resulting in 8.7 kg average weight loss; controls gained 1.8 kg. EE measured over 24 hours or during sleep in the CR group was about 80 to 120 kcal/day lower than expected on the basis of weight loss, indicating a sustained metabolic adaptation. Significantly reduced thyroid axis activity and production of reactive oxygen species (F2-isoprostane) accompanied this adaptation.

"Findings from this two-year CR trial in healthy, non-obese humans provide new evidence of persistent metabolic slowing accompanied by reduced oxidative stress, which supports the rate of living and oxidative damage theories of mammalian aging," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Access to In-Home Support Soon to Be Available for Seniors

Access to In-Home Support Soon to Be Available ...

Under Medicare Advantage, a health-related reason will be needed to qualify; costs will vary

USPSTF Recommends Screening Adults for Unhealthy Alcohol Use

USPSTF Recommends Screening Adults for Unhealthy Alcohol Use

Recommendation applies to all adults, including pregnant women; insufficient evidence for teens

AHA: Icosapent Ethyl Cuts CV Risk From Elevated Triglycerides

AHA: Icosapent Ethyl Cuts CV Risk From Elevated ...

Ischemic events reduced among patients with elevated triglycerides despite taking statins

is free, fast, and customized just for you!




Already a member?

Sign In Now »